A comparison of the effect of meal replacements (FastFX and Optifast) on weight loss prior to Intragastric Balloon Insertio
Not Applicable
Recruiting
- Conditions
- ObesityDiet and Nutrition - Obesity
- Registration Number
- ACTRN12620000643976
- Lead Sponsor
- The Macmurray Gastroenterology and Endoscopy Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
All patients presenting to the clinic and eligible for IGB insertion will be entitled to enrol in the trial. Standard patient selection for IGB insertion will apply: Adults, aged 18–65 years with obesity and a body mass index (BMI) of >27 and <45kgm2
Exclusion Criteria
Patients will be excluded from this trial only if they do not consent to participation or have an allergy to the listed ingredients of the meal replacements.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body weight will measured using a digital balance accurate to 0.02 kg (Amtech Seca 876 Digital Floor Scales) with subjects in underwear after voiding their bladder. The same scale will be used for each recording. [ Patients will be weighed at initial dietician consultation, and the day they begin their Meal Replacements, 1 week prior to balloon insertion, then following their 2 weeks of MR, prior to balloon insertion]
- Secondary Outcome Measures
Name Time Method